- Home
- PMCB vs PAVM Comparison
PMCB vs PAVM Comparison
Compare PMCB & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- PAVM
- Stock Information
- Founded
- PMCB 1996
- PAVM 2014
- Country
- PMCB United States
- PAVM United States
- Employees
- PMCB N/A
- PAVM N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- PAVM Medical/Dental Instruments
- Sector
- PMCB Health Care
- PAVM Health Care
- Exchange
- PMCB Nasdaq
- PAVM Nasdaq
- Market Cap
- PMCB 11.4M
- PAVM 12.0M
- IPO Year
- PMCB N/A
- PAVM 2016
- Fundamental
- Price
- PMCB $1.06
- PAVM $0.69
- Analyst Decision
- PMCB
- PAVM Strong Buy
- Analyst Count
- PMCB 0
- PAVM 1
- Target Price
- PMCB N/A
- PAVM $19.50
- AVG Volume (30 Days)
- PMCB 11.3K
- PAVM 74.9K
- Earning Date
- PMCB 03-17-2025
- PAVM 05-15-2025
- Dividend Yield
- PMCB N/A
- PAVM N/A
- EPS Growth
- PMCB N/A
- PAVM N/A
- EPS
- PMCB 1.29
- PAVM 0.50
- Revenue
- PMCB N/A
- PAVM $2,995,000.00
- Revenue This Year
- PMCB N/A
- PAVM N/A
- Revenue Next Year
- PMCB N/A
- PAVM $457.25
- P/E Ratio
- PMCB $0.85
- PAVM $1.39
- Revenue Growth
- PMCB N/A
- PAVM 22.14
- 52 Week Low
- PMCB $1.03
- PAVM $0.55
- 52 Week High
- PMCB $2.42
- PAVM $2.42
- Technical
- Relative Strength Index (RSI)
- PMCB 36.21
- PAVM 47.02
- Support Level
- PMCB $1.08
- PAVM $0.70
- Resistance Level
- PMCB $1.39
- PAVM $0.80
- Average True Range (ATR)
- PMCB 0.10
- PAVM 0.06
- MACD
- PMCB 0.00
- PAVM -0.01
- Stochastic Oscillator
- PMCB 0.00
- PAVM 30.46
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.